HI
EBS icon

Harbour Investments’s Emergent Biosolutions EBS Stock Holding History

Harbour Investments’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$586 Buy
70
+9
+15% +$75 ﹤0.01% 4336
2026
Q1 		$511 Buy
+61
New +$632 ﹤0.01% 4253
2021
Q4 		– Sell
-60
Closed -$3K – 2908
2021
Q3 		$3K Buy
60
+12
+25% +$727 ﹤0.01% 3167
2021
Q2 		$3K Sell
48
-558
-92% -$35.8K ﹤0.01% 3227
2021
Q1 		$56K Buy
+606
New +$62.1K ﹤0.01% 1625

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Harbour Investments's EBS Position: Q2 2026 in Review

Harbour Investments increased its Emergent Biosolutions (EBS) stake by 15% in Q2 2026, buying an estimated $75 and bringing the position to 70 shares worth $586. The position accounts for ﹤0.01% of the portfolio, ranked #4336.

Harbour Investments first reported a position in EBS in Q1 2021 and has held it in 5 quarters since. The position peaked at $56K in Q1 2021. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Harbour Investments held 70 shares of Emergent Biosolutions worth $586 as of Q2 2026.
  • Harbour Investments bought 9 Emergent Biosolutions shares in Q2 2026, an estimated $75.
  • Emergent Biosolutions made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4336 holding.
  • Harbour Investments first reported a position in Emergent Biosolutions in Q1 2021 and has held it in 5 quarters since.
  • Harbour Investments's Emergent Biosolutions position peaked at $56K in Q1 2021.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.